Semaglutide 5mg: Weight Loss Research Peptide (2nd Photo of COA)

Description

Semaglutide 5mg — a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist designed primarily for advanced diabetes management and weight control research. Known for its efficacy in improving glycemic control and promoting significant weight loss, semaglutide has become an essential compound in studies related to metabolic disorders.

Details

• Quantity: 5 mg
• Packaging: Secure, sealed, and tamper-proof vials
• Source: Werner Science, High-quality lab-grade peptide, Third-party tested
• Note: This product is sold in powder form and must be reconstituted before use.

Research Applications

Semaglutide shows powerful benefits, making it an exciting focus for researchers looking into ways to manage type 2 diabetes and treat obesity. Its ability to stimulate insulin secretion while suppressing glucagon release positions it as a valuable tool in regulating blood sugar levels. Additionally, semaglutide has shown promise in reducing body weight by decreasing hunger and food cravings.

Plus, semaglutide might help lower cardiovascular risks by improving lipid metabolism and regulating blood pressure.

Safety data has highlighted a potential link between semaglutide treatment and an increased risk of retinopathy complications in patients with preexisting diabetic retinopathy.

Key Features

• Amino Acid Sequence: Not specified here; typically involves modifications of natural GLP-1.
• Molecular Weight: Approximately 4 kDa.
• Purity: High-quality lab-grade purity suitable for advanced research applications.

Research Applications

Researchers are exploring semaglutide’s role in:

• Improving blood sugar levels by boosting insulin sensitivity.
• Helping individuals achieve major weight loss by curbing appetite & cravings.
• Investigating potential cardiovascular protective effects.

Studies

[1] https://pmc.ncbi.nlm.nih.gov/articles/PMC6099440/

[2] https://pmc.ncbi.nlm.nih.gov/articles/PMC6231279/

[3] https://apcz.umk.pl/JEHS/article/view/51699

[4] https://journals.viamedica.pl/clinical_diabetology/article/view/102374

[5] https://www.nature.com/articles/s41591-024-02996-7

[6] https://journals.viamedica.pl/clinical_diabetology/article/view/103963/81142

[7] https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.15911

Return To: All Research Peptides

Legal Disclaimer

These peptides are intended solely for laboratory and research purposes. They are not for human or animal use. Purchasers must comply with all applicable laws and regulations. By purchasing, you agree to indemnify and hold harmless our company from any claims arising from the handling or use of these products. Our liability is limited to the purchase price. Adopt all necessary safety precautions when handling the products. All product information and handling information is for informational/research purposes only.  This is governed under Canadian law.

Shipping across Canada, including but not limited to: British Columbia (Victoria, Vancouver, Surrey, Burnaby), Alberta (Edmonton, Calgary, Strathcona County), Saskatchewan (Regina, Saskatoon, Prince Albert), Manitoba (Winnipeg, Brandon), Ontario (Toronto, Ottawa, Mississauga, Hamilton), Quebec (Québec City, Montréal, Laval, Gatineau), New Brunswick (Fredericton, Saint John, Moncton), Nova Scotia (Halifax, Sydney), Prince Edward Island (Charlottetown, Summerside), Newfoundland and Labrador (St. John’s, Conception Bay South), Yukon (Whitehorse, Dawson City), Northwest Territories (Yellowknife, Hay River), Nunavut (Iqaluit, Arviat).